Add BrightSurf on Google Email

The Lancet


Dangers in the garden

A previously fit man contracted Legionnaire's disease after cutting his finger on compost, highlighting the risk of infection through gardening activities. The UK Royal Horticultural Society has announced cautionary statements on potting compost bags to warn gardeners about this rare but serious risk.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 2, 2010

Study shows sugar given to newborn babies does not relieve pain, it only changes facial expressions for some babies

A study published in The Lancet reveals that giving newborn babies oral sucrose does not relieve pain, but rather changes their facial expressions. Researchers administered sucrose or sterile water to 59 infants before undergoing heel lances and found no significant difference in brain activity or spinal reflex withdrawal, but a lower ...

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 1, 2010

Heart-rate-lowering drug ivabradine reduces death and hospitalization when added to standard treatments in patients with heart failure

The SHIFT study found that ivabradine significantly reduced cardiovascular death and hospitalization for worsening heart failure when added to standard treatment in patients with a high heart rate. Lowering heart rates with ivabradine was also associated with improved clinical outcomes, including an average reduction of 15 bpm.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 29, 2010

Genetic variation in key cell pumping mechanism reduces effects of clopidogrel treatment (but not prasugrel), leaving those affected at increased risk of cardiovascular events

A study found that genetic variation in ABCB1 affects clopidogrel metabolism, leading to increased cardiovascular risk. The variation, which is common in half the population, can render standard clopidogrel treatment less effective, highlighting the importance of personalized medicine approaches.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 29, 2010

Addition of trastuzumab to chemotherapy for stomach cancer extends survival by nearly 3 months, but is it cost effective?

A phase 3 trial found trastuzumab improves median survival to 13.8 months for HER2-positive advanced gastric cancer patients, with a 26% reduction in death rate compared to chemotherapy alone. The treatment's cost effectiveness is questioned due to its estimated £13,857 per patient cost and $55,000 cost per life-year gained.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 19, 2010

Use of specialist retrieval teams to transport sick children to pediatric intensive care units is associated with reduced mortality

A study published in The Lancet found that specialist retrieval teams significantly reduce mortality rates among children transferred to pediatric intensive care units. Children admitted from other hospitals had better outcomes and lower mortality rates when transferred by specialist teams compared to non-specialist transfers.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 11, 2010

Injection of bone cement (vertebroplasty) is safe, effective and at an acceptable cost for patients with acute osteoporotic vertebral compression fractures

Vertebroplasty is effective in providing greater pain relief than conservative treatment, resulting in a significant reduction in Visual Analog Scale (VAS) scores. Patients experienced immediate and sustained pain relief lasting up to one year, making it a safe option for those with acute fractures.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 9, 2010

Home birth: Proceed with caution

Recent meta-analysis finds planned home births double the risk of neonatal deaths and triple when infants have congenital defects. Women should receive adequate midwife care and have quick access to hospital equipment for safe delivery.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 29, 2010

What is stopping timely stroke care in the UK?

A recent report from the UK Vascular Society and Royal College of Physicians reveals patients in the UK are waiting too long for vascular surgery after stroke or TIA symptoms. The main causes of delays include delayed referral, scarcity of staff or operating theatres, and patient presentation issues.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 29, 2010

Study establishes most effective technique for diagnosing childhood tuberculosis in resource-poor countries

A new diagnostic technique called microscopic-observation drug-susceptibility (MODS) has been shown to be significantly more sensitive and faster than conventional culture tests, diagnosing 70% more cases of pulmonary TB among children under 12. This is the best available test for confirming paediatric pulmonary tuberculosis in resourc...

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateJul 25, 2010

Women, but not men, who are exposed to radiation therapy as children much more prone to stillbirths or baby death when attempting to have children

A new study published in The Lancet found that women who underwent radiation therapy as children are more likely to experience stillbirths or baby deaths when attempting to conceive. In contrast, no increased risk was found for men exposed to similar levels of radiation. The authors suggest that uterine damage may be the primary factor...

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 22, 2010

Nitric oxide does not prevent poor lung development or increase survival of preterm infants overall, but black babies did better than non-black

A randomized controlled trial found that nitric oxide treatment did not improve overall survival or reduce poor lung development in preterm infants. However, black babies showed a higher survival rate compared to non-black babies. The study suggests that ethnic origin may affect the response to nitric oxide treatment.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 21, 2010

Less than 10 percent of injecting drug users covered by existing HIV prevention interventions; huge scale-up of combined approaches needed

Less than 1 in 10 injecting drug users globally are covered by effective HIV prevention interventions, with most relying on a combination of needle and syringe programs, opioid substitution therapy, and antiretroviral therapy. Scaling up these combined approaches is crucial to reduce HIV transmission among IDUs.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 20, 2010

Inadequate provision of treatments, plus laws prohibiting opioid substitution, all driving drug-related HIV epidemics

Experts conclude that inadequate provision of opioid substitution therapy, needle exchange programs, and antiretroviral treatment, along with laws prohibiting OST, are all contributing to the spread of HIV among people who use drugs. Scaling up combination HIV prevention interventions is shown to be effective in curbing the epidemic.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 20, 2010

Drug users must be decriminalized along with scale-up of combination treatment and changes to drug control and law enforcement

Experts call for decriminalization of drug users, alongside a massive scale-up of opioid substitution, needle and syringe programs, and antiretroviral treatment. Current treatment programmes only reach around 10% of people who use drugs worldwide, highlighting the need for reform in justice systems and policy decision making.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 20, 2010